Sanofi saw slight gains yesterday after the company announced big news that it would be buying Amunix Pharmaceuticals Inc. Shares rose about 0.8% in trading as Wall Street learned that Sanofi would be acquiring the privately held immuno-oncology company. The acquisition is worth $1 billion upfront and another $225 million in milestone payments. The deal … Continue reading “Sanofi to Acquire Amunix Pharmaceuticals Inc.”
